Korean J Pain.  2021 Oct;34(4):509-533. 10.3344/kjp.2021.34.4.509.

Pharmacological and non-pharmacological strategies for preventing postherpetic neuralgia: a systematic review and network meta-analysis

• Kim J
• Kim MK
• Choi GJ
• Shin HY
• Kim BG
• Kang H

• KMID: 2520759
• DOI: http://doi.org/10.3344/kjp.2021.34.4.509

Abstract

Background
Postherpetic neuralgia (PHN) is a refractory complication of herpes zoster (HZ). To prevent PHN, various strategies have been aggressively adopted. However, the efficacy of these strategies remains controversial. Therefore, we aimed to estimate the relative efficacy of various strategies used in clinical practice for preventing PHN using a network meta-analysis (NMA).
Methods
We performed a systematic and comprehensive search to identify all randomized controlled trials. The primary outcome was the incidence of PHN at 3 months after acute HZ. We performed both frequentist and Bayesian NMA and used the surface under the cumulative ranking curve (SUCRA) values to rank the interventions evaluated.
Results
In total, 39 studies were included in the systematic review and NMA. According to the SUCRA value, the incidence of PHN was lower in the order of continuous epidural block with local anesthetics and steroids (EPI-LSE), antiviral agents with subcutaneous injection of local anesthetics and steroids (AV + sLS), antiviral agents with intracutaenous injection of local anesthetics and steroids (AV + iLS) at 3 months after acute HZ. EPI-LSE, AV + sLS and AV + iLS were also effective in preventing PHN at 1 month after acute HZ. And paravertebral block combined with antiviral and antiepileptic agents was effective in preventing PHN at 1, 3, and 6 months.
Conclusions
The continuous epidural block with local anesthetics and steroid, antiviral agents with intracutaneous or subcutaneous injection of local anesthetics and a steroid, and paravertebral block combined with antiviral and antiepileptic agents are effective in preventing PHN.

Keyword

Anesthesia; Local; Anticonvulsants; Autonomic Nerve Block; Bayes Theorem; Injections; Epidural

Figure

• 

  Fig. 1 Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) flowchart of included and excluded trials. RCT: randomized controlled trial.

• 

  Fig. 2 Network plot of included studies. The nodes show each strategy and the edges show the available direct comparisons among the strategies. The nodes and edges are weighed based on the number of included patients and inverse of standard error of effect. (A) The incidence of postherpetic neuralgia at 3 months after acute herpes zoster, (B) the incidence of postherpetic neuralgia at 1 month after acute herpes zoster, (C) the incidence of postherpetic neuralgia at 6 months after acute herpes zoster, (D) pain score measured at 3 months after acute herpes zoster, (E) pain score measured at 1 month after acute herpes zoster, and (F) pain score measured at 6 months after acute herpes zoster. CTR: control, RTx: radiotherapy, VZVIG: varicella zoster vaccine immunoglobulin, ACTH: adrenocorticotrophic hormone.

• 

  Fig. 3 Inconsistency plot between the direct and indirect effect estimates for the same comparison. Inconsistency factor (IF) as the absolute difference with 95% confidence interval (CI) between the direct and indirect estimates for each paired comparison is presented. IF values close to 0 indicate that the two sources are in agreement. (A) The incidence of postherpetic neuralgia at 3 months after acute herpes zoster, (B) the incidence of postherpetic neuralgia at 1 month after acute herpes zoster, (C) the incidence of postherpetic neuralgia at 6 months after acute herpes zoster, (D) pain score measured at 3 months after acute herpes zoster, and (E) pain score measured at 1 month after acute herpes zoster.

• 

  Fig. 4 Predictive interval plots (PrIs) compared with control. A diamond shape represents the mean summary effects. The black line represents the 95% confidence interval (CI), and the red line represents the PrI. PrIs provide an interval that is expected to encompass the estimate of a future study. (A) The incidence of postherpetic neuralgia at 3 months after acute herpes zoster, (B) the incidence of postherpetic neuralgia at 1 month after acute herpes zoster, and (C) the incidence of postherpetic neuralgia at 6 months after acute herpes zoster. CTR: control, RTx: radiotherapy, VZVIG: varicella zoster vaccine immunoglobulin, ACTH: adrenocorticotrophic hormone.

• 

  Fig. 5 The expected mean ranking and surface of under cumulative ranking curve (SUCRA) values for each strategy. The X-axis corresponds to the expected mean ranking based on the SUCRA value, and the Y-axis corresponds to the SUCRA value. (A) The incidence of postherpetic neuralgia at 3 months after acute herpes zoster, (B) the incidence of postherpetic neuralgia at 1 month after acute herpes zoster, (C) the incidence of postherpetic neuralgia at 6 months after acute herpes zoster, (D) pain score measured at 3 months after acute herpes zoster, and (E) pain score measured at 1 month after acute herpes zoster.

• 

  Fig. 6 Comparison-adjusted funnel plot. (A) The incidence of postherpetic neuralgia at 3 months after acute herpes zoster, (B) the incidence of postherpetic neuralgia at 1 month after acute herpes zoster, (C) the incidence of postherpetic neuralgia at 6 months after acute herpes zoster, (D) pain score measured at 3 months after acute herpes zoster, and (E) pain score measured at 1 month after acute herpes zoster.

• 

  Fig. 7 The surface of under cumulative ranking curve (SUCRA) values from the Bayesian model compared with SUCRA values from the frequentist model. The X-axis corresponds to the SUCRA values from the frequentist model and the Y-axis corresponds to the SUCRA values from the Bayesian model. (A) The incidence of postherpetic neuralgia at 3 months after acute herpes zoster, (B) the incidence of postherpetic neuralgia at 1 month after acute herpes zoster, (C) the incidence of postherpetic neuralgia at 6 months after acute herpes zoster, (D) pain score measured at 3 months after acute herpes zoster, (E) pain score measured at 1 month after acute herpes zoster.

Reference

1. Kawai K, Gebremeskel BG, Acosta CJ. 2014; Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 4:e004833. DOI: 10.1136/bmjopen-2014-004833. PMID: 24916088. PMCID: PMC4067812.

2. Yawn BP, Gilden D. 2013; The global epidemiology of herpes zoster. Neurology. 81:928–30. DOI: 10.1212/WNL.0b013e3182a3516e. PMID: 23999562. PMCID: PMC3885217.

3. Johnson RW, Alvarez-Pasquin MJ, Bijl M, Franco E, Gaillat J, Clara JG, et al. 2015; Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. Ther Adv Vaccines. 3:109–20. DOI: 10.1177/2051013615599151. PMID: 26478818. PMCID: PMC4591524.

4. Erskine N, Tran H, Levin L, Ulbricht C, Fingeroth J, Kiefe C, et al. 2017; A systematic review and meta-analysis on herpes zoster and the risk of cardiac and cerebrovascular events. PLoS One. 12:e0181565. DOI: 10.1371/journal.pone.0181565. PMID: 28749981. PMCID: PMC5531458.

5. Forbes HJ, Thomas SL, Smeeth L, Clayton T, Farmer R, Bhaskaran K, et al. 2016; A systematic review and meta-analysis of risk factors for postherpetic neuralgia. Pain. 157:30–54. DOI: 10.1097/j.pain.0000000000000307. PMID: 26218719. PMCID: PMC4685754.

6. Nahm FS, Kim SH, Kim HS, Shin JW, Yoo SH, Yoon MH, et al. 2013; Survey on the treatment of postherpetic neuralgia in Korea; multicenter study of 1,414 patients. Korean J Pain. 26:21–6. DOI: 10.3344/kjp.2013.26.1.21. PMID: 23342203. PMCID: PMC3546205.

7. Sacks GM. 2013; Unmet need in the treatment of postherpetic neuralgia. Am J Manag Care. 19(1 Suppl):S207–13. PMID: 23448093.

8. Johnson RW, Bouhassira D, Kassianos G, Leplège A, Schmader KE, Weinke T. 2010; The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med. 8:37. DOI: 10.1186/1741-7015-8-37. PMID: 20565946. PMCID: PMC2905321.

9. Schmader KE. 2002; Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain. 18:350–4. DOI: 10.1097/00002508-200211000-00002. PMID: 12441828.

10. Xing XF, Zhou ZF, Zhang FJ, Yan M. 2017; The effect of early use of supplemental therapy on preventing postherpetic neuralgia: a systematic review and meta-analysis. Pain Physician. 20:471–86. DOI: 10.36076/ppj.2017.20.5.471. PMID: 28934778.

11. Han Y, Zhang J, Chen N, He L, Zhou M, Zhu C. 2013; Corticosteroids for preventing postherpetic neuralgia. Cochrane Database Syst Rev. (3):CD005582. DOI: 10.1002/14651858.CD005582.pub4. PMID: 23543541.

12. Chen N, Li Q, Yang J, Zhou M, Zhou D, He L. 2014; Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev. (2):CD006866. DOI: 10.1002/14651858.CD006866.pub3. PMID: 24500927.

13. Kim HJ, Ahn HS, Lee JY, Choi SS, Cheong YS, Kwon K, et al. 2017; Effects of applying nerve blocks to prevent postherpetic neuralgia in patients with acute herpes zoster: a systematic review and meta-analysis. Korean J Pain. 30:3–17. DOI: 10.3344/kjp.2017.30.1.3. PMID: 28119767. PMCID: PMC5256258.

14. Jansen JP, Naci H. 2013; Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers. BMC Med. 11:159. DOI: 10.1186/1741-7015-11-159. PMID: 23826681. PMCID: PMC3707819.

15. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. 2015; Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 350:g7647. DOI: 10.1136/bmj.g7647. PMID: 25555855.

16. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. 2019. Cochrane handbook for systematic reviews of interventions. 2nd ed. John Wiley & Sons;Chichester: https://www.worldcat.org/title/cochrane-handbook-for-systematic-reviews-of-interventions/oclc/1245192202?referer=br&ht=edition. DOI: 10.1002/9781119536604.

17. Cornell JE. 2015; The PRISMA extension for network meta-analysis: bringing clarity and guidance to the reporting of systematic reviews incorporating network meta-analyses. Ann Intern Med. 162:797–8. DOI: 10.7326/M15-0930. PMID: 26030637.

18. Viera AJ, Garrett JM. 2005; Understanding interobserver agreement: the kappa statistic. Fam Med. 37:360–3. PMID: 15883903.

19. Higgins JPT, Sterne JAC, Savović J, Page MJ, Hróbjartsson A, Boutron I, et al. 2016; A revised tool for assessing risk of bias in randomized trials. Cochrane Database Syst Rev. 10 Suppl 1:29–31. https://research.monash.edu/en/publications/a-revised-tool-for-assessing-risk-of-bias-in-randomized-trials.

20. Chaimani A, Higgins JP, Mavridis D, Spyridonos P, Salanti G. 2013; Graphical tools for network meta-analysis in STATA. PLoS One. 8:e76654. DOI: 10.1371/journal.pone.0076654. PMID: 24098547. PMCID: PMC3789683.

21. White IR, Barrett JK, Jackson D, Higgins JP. 2012; Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression. Res Synth Methods. 3:111–25. DOI: 10.1002/jrsm.1045. PMID: 26062085. PMCID: PMC4433771.

22. Salanti G, Ades AE, Ioannidis JP. 2011; Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 64:163–71. DOI: 10.1016/j.jclinepi.2010.03.016. PMID: 20688472.

23. Riley RD, Higgins JP, Deeks JJ. 2011; Interpretation of random effects meta-analyses. BMJ. 342:d549. DOI: 10.1136/bmj.d549. PMID: 21310794.

24. van Valkenhoef G, Lu G, de Brock B, Hillege H, Ades AE, Welton NJ. 2012; Automating network meta-analysis. Res Synth Methods. 3:285–99. DOI: 10.1002/jrsm.1054. PMID: 26053422.

25. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. 2004; Grading quality of evidence and strength of recommendations. BMJ. 328:1490. DOI: 10.1136/bmj.328.7454.1490. PMID: 15205295. PMCID: PMC428525.

26. Canadian Pain Society Study Day participants. 2015; Safety and effectiveness of the herpes zoster vaccine to prevent postherpetic neuralgia: 2014 update and consensus statement from the Canadian Pain Society. Pain Res Manag. 20:46–7. DOI: 10.1155/2015/438597. PMID: 25664540. PMCID: PMC4325890.

27. Dworkin RH, Boon RJ, Griffin DR, Phung D. 1998; Postherpetic neuralgia: impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients. J Infect Dis. 178 Suppl 1:S76–80. DOI: 10.1086/514260. PMID: 9852980.

28. Dworkin RH, Schmader KE. 2003; Treatment and prevention of postherpetic neuralgia. Clin Infect Dis. 36:877–82. DOI: 10.1086/368196. PMID: 12652389.

29. Gawecka E, Viken O. 2012; Postherpetic neuralgia: new hopes in prevention with adult vaccination and in treatment with a concentrated capsaicin patch. Scand J Pain. 3:220–8. DOI: 10.1016/j.sjpain.2012.05.070. PMID: 29913873.

30. Gilden D. 2011; Efficacy of live zoster vaccine in preventing zoster and postherpetic neuralgia. J Intern Med. 269:496–506. DOI: 10.1111/j.1365-2796.2011.02359.x. PMID: 21294791. PMCID: PMC3083261.

31. Jackson JL, Gibbons R, Meyer G, Inouye L. 1997; The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia. A meta-analysis. Arch Intern Med. 157:909–12. DOI: 10.1001/archinte.1997.00440290095010. PMID: 9129551.

32. Wood MJ, Kay R, Dworkin RH, Soong SJ, Whitley RJ. 1996; Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis. 22:341–7. DOI: 10.1093/clinids/22.2.341. PMID: 8838194.

33. Wu CL, Marsh A, Dworkin RH. 2000; The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia. Pain. 87:121–9. DOI: 10.1016/S0304-3959(00)00230-X. PMID: 10924805.

34. Huff JC, Drucker JL, Clemmer A, Laskin OL, Connor JD, Bryson YJ, et al. 1993; Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysis. J Med Virol. Suppl 1:93–6. DOI: 10.1002/jmv.1890410518. PMID: 8245901.

35. Surman OS, Flynn T, Schooley RT, Baer L, Parker S, Hirsch MS, et al. 1990; A double-blind, placebo-controlled study of oral acyclovir in postherpetic neuralgia. Psychosomatics. 31:287–92. DOI: 10.1016/S0033-3182(90)72166-4. PMID: 2201992.

36. Whitley RJ, Weiss H, Gnann JW Jr, Tyring S, Mertz GJ, Pappas PG, et al. 1996; Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med. 125:376–83. DOI: 10.7326/0003-4819-125-5-199609010-00004. PMID: 8702088.

37. Balakrishnan S, Bhushan K, Bhargava VK, Pandhi P. 2001; A randomized parallel trial of topical aspirin-moisturizer solution vs. oral aspirin for acute herpetic neuralgia. Int J Dermatol. 40:535–8. DOI: 10.1046/j.1365-4362.2001.01265.x. PMID: 11703529.

38. Bareggi SR, Pirola R, De Benedittis G. 1998; Skin and plasma levels of acetylsalicylic acid: a comparison between topical aspirin/diethyl ether mixture and oral aspirin in acute herpes zoster and postherpetic neuralgia. Eur J Clin Pharmacol. 54:231–5. DOI: 10.1007/s002280050451. PMID: 9681665.

39. Bruni L, Tagliapietra G, Innocenti P. 1984; Herpes zoster treatments: results of a clinical trial relative to the use of rifamycin SV versus neuramide. J Int Med Res. 12:255–60. DOI: 10.1177/030006058401200406. PMID: 6381169.

40. Dworkin RH, Barbano RL, Tyring SK, Betts RF, McDermott MP, Pennella-Vaughan J, et al. 2009; A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster. Pain. 142:209–17. DOI: 10.1016/j.pain.2008.12.022. PMID: 19195785.

41. Higa K, Hori K, Harasawa I, Hirata K, Dan K. 1998; High thoracic epidural block relieves acute herpetic pain involving the trigeminal and cervical regions: comparison with effects of stellate ganglion block. Reg Anesth Pain Med. 23:25–9. DOI: 10.1097/00115550-199823010-00007. PMID: 9552775.

42. Isbary G, Shimizu T, Zimmermann JL, Heinlin J, Al-Zaabi S, Rechfeld M, et al. 2014; Randomized placebo-controlled clinical trial showed cold atmospheric argon plasma relieved acute pain and accelerated healing in herpes zoster. Clin Plasma Med. 2:50–5. https://doi.org/10.1016/j.cpme.2014.07.001. DOI: 10.1016/j.cpme.2014.07.001.

43. Jensen-Dahm C, Rowbotham MC, Reda H, Petersen KL. 2011; Effect of a single dose of pregabalin on herpes zoster pain. Trials. 12:55. DOI: 10.1186/1745-6215-12-55. PMID: 21356040. PMCID: PMC3059274.

44. Liang L, Li X, Zhang G, Sun Y, Yu H, Jiao J. 2015; Pregabalin in the treatment of herpetic neuralgia: results of a multicenter Chinese study. Pain Med. 16:160–7. DOI: 10.1111/pme.12564. PMID: 25597438.

45. Lin PL, Fan SZ, Huang CH, Huang HH, Tsai MC, Lin CJ, et al. 2008; Analgesic effect of lidocaine patch 5% in the treatment of acute herpes zoster: a double-blind and vehicle-controlled study. Reg Anesth Pain Med. 33:320–5. DOI: 10.1097/00115550-200807000-00006. PMID: 18675742.

46. McKendrick MW, Care C, Burke C, Hickmott E, McKendrick GD. 1984; Oral acyclovir in herpes zoster. J Antimicrob Chemother. 14:661–5. DOI: 10.1093/jac/14.6.661. PMID: 6394572.

47. Mondelli M, Romano C, Passero S, Porta PD, Rossi A. 1996; Effects of acyclovir on sensory axonal neuropathy, segmental motor paresis and postherpetic neuralgia in herpes zoster patients. Eur Neurol. 36:288–92. DOI: 10.1159/000117274. PMID: 8864710.

48. Winnie AP, Hartwell PW. 1993; Relationship between time of treatment of acute herpes zoster with sympathetic blockade and prevention of post-herpetic neuralgia: clinical support for a new theory of the mechanism by which sympathetic blockade provides therapeutic benefit. Reg Anesth. 18:277–82. PMID: 8268115.

49. Hui F, Boyle E, Vayda E, Glazier RH. 2012; A randomized controlled trial of a multifaceted integrated complementary-alternative therapy for chronic herpes zoster-related pain. Altern Med Rev. 17:57–68. PMID: 22502623.

50. Juel-Jensen BE, Khan JA, Pasvol G. 1983; High-dose intravenous acyclovir in the treatment of zoster: a double-blind, placebo-controlled trial. J Infect. 6(1 Suppl):31–6. DOI: 10.1016/S0163-4453(83)94096-3. PMID: 6350473.

51. Kikuchi A, Kotani N, Sato T, Takamura K, Sakai I, Matsuki A. 1999; Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for long-term analgesia in patients with intractable postherpetic neuralgia. Reg Anesth Pain Med. 24:287–93. DOI: 10.1097/00115550-199924040-00003. PMID: 10445766.

52. van den Broek PJ, van der Meer JW, Mulder JD, Versteeg J, Mattie H. 1984; Limited value of acyclovir in the treatment of uncomplicated herpes zoster: a placebo-controlled study. Infection. 12:338–41. DOI: 10.1007/BF01651148. PMID: 6392105.

53. Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ. 1995; Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother. 39:1546–53. DOI: 10.1128/AAC.39.7.1546. PMID: 7492102. PMCID: PMC162779.

54. Yanagida H, Suwa K, Corssen G. 1987; No prophylactic effect of early sympathetic blockade on postherpetic neuralgia. Anesthesiology. 66:73–6. DOI: 10.1097/00000542-198701000-00015. PMID: 3800039.

55. Sederholm B, Peterson D. 2006; Zoster vaccine to prevent postherpetic neuralgia. J Pain Palliat Care Pharmacother. 20:41–2. DOI: 10.1080/J354v20n04_07. PMID: 17182505.

56. Dai J, Yin AH, Zhou Y, Yin LJ. 2011; Herpes zoster treated with meridian-collateral electric information therapy combined with pricking and cupping. Zhongguo Zhen Jiu. 31:416–9. Chinese. PMID: 21692286.

57. Fujii H, Fukushima T, Ishii M, Nagano Y, Kawanishi S, Watanabe Y, et al. 2009; The efficacy of intravenous lidocaine for acute herpetic pain--placebo controlled trial. Masui. 58:1413–7. Japanese. PMID: 19928509.

58. Galbraith AW. 1983; Prevention of post-herpetic neuralgia by amantadine hydrochloride (Symmetrel). Br J Clin Pract. 37:304–6. PMID: 6354236.

59. Morton P, Thomson AN. 1989; Oral acyclovir in the treatment of herpes zoster in general practice. N Z Med J. 102:93–5. PMID: 2648213.

60. Peng Z, Wang S, Huang X, Xiao P. 2012; Effect of hyperbaric oxygen therapy on patients with herpes zoster. Undersea Hyperb Med. 39:1083–7. PMID: 23342765.

61. Varotti C, Rafanelli A. 2001; Evaluation of efficacy and tolerance of neuramide in the treatment of herpes zoster and postherpetic neuritis. Drugs Exp Clin Res. 27:199–208. PMID: 11951578.

62. Wood MJ, Ogan PH, McKendrick MW, Care CD, McGill JI, Webb EM. 1988; Efficacy of oral acyclovir treatment of acute herpes zoster. Am J Med. 85(2A):79–83. PMID: 3044098.

63. Harding SP, Lipton JR, Wells JC. 1987; Natural history of herpes zoster ophthalmicus: predictors of postherpetic neuralgia and ocular involvement. Br J Ophthalmol. 71:353–8. DOI: 10.1136/bjo.71.5.353. PMID: 3495293. PMCID: PMC1041165.

64. Barbarisi M, Pace MC, Passavanti MB, Maisto M, Mazzariello L, Pota V, et al. 2010; Pregabalin and transcutaneous electrical nerve stimulation for postherpetic neuralgia treatment. Clin J Pain. 26:567–72. DOI: 10.1097/AJP.0b013e3181dda1ac. PMID: 20639738.

65. Guo W, Xiao Z, Yang Y. 2007; Effectiveness of transdermal fentanyl combined with clodine for pain control of acute herpes zoster. J Dalian Med Univ. 29:255–6. https://caod.oriprobe.com/articles/12353548/Effectiveness_of_transdermal_fentanyl_combined_with_clodine_for_pain_c.htm.

66. Tenicela R, Lovasik D, Eaglstein W. 1985; Treatment of herpes zoster with sympathetic blocks. Clin J Pain. 1:63–8. https://journals.lww.com/clinicalpain/Abstract/1985/01020/Treatment_of_Herpes_Zoster_with_Sympathetic.2.aspx. DOI: 10.1097/00002508-198501020-00002.

67. Wang JS. 2002; The comparison of therapeutic effect of three methods for the treatment of acute herpes zoster. Curr Opin Clin Exp Res. 4:12–5.

68. Huff JC, Bean B, Balfour HH Jr, Laskin OL, Connor JD, Corey L, et al. 1988; Therapy of herpes zoster with oral acyclovir. Am J Med. 85(2A):84–9. PMID: 3044099.

69. McKendrick MW, McGill JI, White JE, Wood MJ. 1986; Oral acyclovir in acute herpes zoster. Br Med J (Clin Res Ed). 293:1529–32. DOI: 10.1136/bmj.293.6561.1529. PMID: 3099943. PMCID: PMC1342307.

70. Opstelten W, van Wijck AJ, Moons KG, van Essen GA, Stolker RJ, Kalkman CJ, et al. 2006; Treatment of patients with herpes zoster by epidural injection of steroids and local anaesthetics: less pain after 1 month, but no effect on long-term postherpetic neuralgia--a randomised trial. Ned Tijdschr Geneeskd. 150:2649–55. Dutch. PMID: 17205943.

71. Peterslund NA, Seyer-Hansen K, Ipsen J, Esmann V, Schonheyder H, Juhl H. 1981; Acyclovir in herpes zoster. Lancet. 2:827–30. DOI: 10.1016/S0140-6736(81)91102-8. PMID: 6116951.

72. Colin J, Prisant O, Cochener B, Lescale O, Rolland B, Hoang-Xuan T. 2000; Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus. Ophthalmology. 107:1507–11. DOI: 10.1016/S0161-6420(00)00222-0. PMID: 10919899.

73. Fujiwara A, Watanabe K, Hashizume K, Shinohara K, Kawaguchi M. 2018; Transforaminal vs interlaminar epidural steroid injection for acute-phase shingles: a randomized, prospective trial. Pain Physician. 21:373–82. DOI: 10.36076/ppj.2018.4.373. PMID: 30045594.

74. Hoang-Xuan T, Büchi ER, Herbort CP, Denis J, Frot P, Thénault S, et al. 1992; Oral acyclovir for herpes zoster ophthalmicus. Ophthalmology. 99:1062–70. DOI: 10.1016/S0161-6420(92)31849-4. PMID: 1495785.

75. Tyring SK, Beutner KR, Tucker BA, Anderson WC, Crooks RJ. 2000; Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. Arch Fam Med. 9:863–9. DOI: 10.1001/archfami.9.9.863. PMID: 11031393.

76. Sharif S, Aslam F, Faisal LR, Saleem MA. 2019; Comparison of efficacy of two different doses of famciclovir in the prevention and treatment of postherpetic neuralgia. J Ayub Med Coll Abbottabad. 31(4 Suppl 1):S668–71. PMID: 31965772.

77. Tyring SK, Lee P, Hill GT Jr, Silverfield JC, Moore AY, Matkovits T, et al. 2017; FV-100 versus valacyclovir for the prevention of post-herpetic neuralgia and the treatment of acute herpes zoster-associated pain: a randomized-controlled trial. J Med Virol. 89:1255–64. DOI: 10.1002/jmv.24750. PMID: 27943311. PMCID: PMC6139434.

78. Finn R, Smith MA. 1984; Oral acyclovir for herpes zoster. Lancet. 2:575. DOI: 10.1016/S0140-6736(84)90785-2. PMID: 6148641.

79. Hwang SM, Kang YC, Lee YB, Yoon KB, Ahn SK, Choi EH. 1999; The effects of epidural blockade on the acute pain in herpes zoster. Arch Dermatol. 135:1359–64. DOI: 10.1001/archderm.135.11.1359. PMID: 10566834.

80. Malin JP. 1993; A retrospective and an observational study with acyclovir. J Med Virol. Suppl 1:102–5. DOI: 10.1002/jmv.1890410520. PMID: 8245873.

81. Colding A. 1973; Treatment of pain: organization of a pain clinic: treatment of acute herpes zoster. Proc R Soc Med. 66:541–3. DOI: 10.1177/003591577306600622. PMID: 4781808. PMCID: PMC1645017.

82. Colding A. 1969; The effect of regional sympathetic blocks in the treatment of herpes zoster: a survey of 300 cases. Acta Anaesthesiol Scand. 13:133–41. https://doi.org/10.1111/j.1399-6576.1969.tb00440.x. DOI: 10.1111/j.1399-6576.1969.tb00440.x.

83. Bean B, Braun C, Balfour HH Jr. 1982; Acyclovir therapy for acute herpes zoster. Lancet. 2:118–21. DOI: 10.1016/S0140-6736(82)91090-X. PMID: 6123837.

84. Esmann V, Ipsen J, Peterslund NA, Seyer-Hansen K, Schønheyder H, Juhl H. 1982; Therapy of acute herpes zoster with acyclovir in the nonimmunocompromised host. Am J Med. 73(1A):320–5. DOI: 10.1016/0002-9343(82)90116-4. PMID: 7102712.

85. Balfour HH Jr, Bean B, Laskin OL, Ambinder RF, Meyers JD, Wade JC, et al. 1983; Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med. 308:1448–53. DOI: 10.1056/NEJM198306163082404. PMID: 6343861.

86. McGill J, MacDonald DR, Fall C, McKendrick GD, Copplestone A. 1983; Intravenous acyclovir in acute herpes zoster infection. J Infect. 6:157–61. DOI: 10.1016/S0163-4453(83)92787-1. PMID: 6348177.

87. Cobo LM, Foulks GN, Liesegang T, Lass J, Sutphin JE, Wilhelmus K, et al. 1986; Oral acyclovir in the treatment of acute herpes zoster ophthalmicus. Ophthalmology. 93:763–70. DOI: 10.1016/S0161-6420(86)33678-9. PMID: 3488532.

88. Esmann V, Geil JP, Kroon S, Fogh H, Peterslund NA, Petersen CS, et al. 1987; Prednisolone does not prevent post-herpetic neuralgia. Lancet. 2:126–9. DOI: 10.1016/S0140-6736(87)92331-2.

89. Wassilew SW, Reimlinger S, Nasemann T, Jones D. 1987; Oral acyclovir for herpes zoster: a double-blind controlled trial in normal subjects. Br J Dermatol. 117:495–501. DOI: 10.1111/j.1365-2133.1987.tb04930.x. PMID: 3314973.

90. Mandal BK, Dunbar EM, Ellis ME, Ellis J, Dowd P. 1988; A double-masked, placebo-controlled trial of acyclovir cream in immunocompetent patients with herpes zoster. J Infect. 17:57–63. DOI: 10.1016/S0163-4453(88)92356-0. PMID: 3060542.

91. Payne CM, Menday AP, Rogers T, Staughton RC. 1989; Isoprinosine does not influence the natural history of herpes zoster or postherpetic neuralgia. Scand J Infect Dis. 21:15–8. DOI: 10.3109/00365548909035675. PMID: 2471260.

92. Benoldi D, Mirizzi S, Zucchi A, Allegra F. 1991; Prevention of post-herpetic neuralgia. Evaluation of treatment with oral prednisone, oral acyclovir, and radiotherapy. Int J Dermatol. 30:288–90. DOI: 10.1111/j.1365-4362.1991.tb04642.x. PMID: 2050460.

93. Bowsher D. 1997; The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage. 13:327–31. DOI: 10.1016/S0885-3924(97)00077-8. PMID: 9204652.

94. Ahmed HE, Craig WF, White PF, Ghoname ES, Hamza MA, Gajraj NM, et al. 1998; Percutaneous electrical nerve stimulation: an alternative to antiviral drugs for acute herpes zoster. Anesth Analg. 87:911–4. DOI: 10.1097/00000539-199810000-00031. PMID: 9768793.

95. Lee IH, Kim BS, Lee SC, Jo DH. 1999; The effect of stellate ganglion block on the pain of acute stage and the prevention of postherpetic neuralgin in the treatment of senile herpes zoster patients. Korean J Dermatol. 37:571–9.

96. van Wijck AJ, Opstelten W, Moons KG, van Essen GA, Stolker RJ, Kalkman CJ, et al. 2006; The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trial. Lancet. 367:219–24. DOI: 10.1016/S0140-6736(06)68032-X. PMID: 16427490.

97. Ji G, Niu J, Shi Y, Hou L, Lu Y, Xiong L. 2009; The effectiveness of repetitive paravertebral injections with local anesthetics and steroids for the prevention of postherpetic neuralgia in patients with acute herpes zoster. Anesth Analg. 109:1651–5. DOI: 10.1213/ANE.0b013e3181b79075. PMID: 19713253.

98. Krcevski Skvarc N, Kamenik M. 2010; Effects of pregabalin on acute herpetic pain and postherpetic neuralgia incidence. Wien Klin Wochenschr. 122 Suppl 2:49–53. DOI: 10.1007/s00508-010-1345-x. PMID: 20517672.

99. Kanodia SK, Singhal KC. 2011; A study on efficacy of Pregabalin in acute Herpetic Neuralgia. Ann Neurosci. 18:148–50. DOI: 10.5214/ans.0972.7531.1118405. PMID: 25205945. PMCID: PMC4116962.

100. Kanodia SK, Seth AK, Dixit AM. 2012; Dose related efficacy of gabapentin in acute herpetic neuralgia among geriatric patients. Indian J Dermatol. 57:362–5. DOI: 10.4103/0019-5154.100476. PMID: 23112355. PMCID: PMC3482798.

101. Makharita MY, Amr YM, El-Bayoumy Y. 2012; Effect of early stellate ganglion blockade for facial pain from acute herpes zoster and incidence of postherpetic neuralgia. Pain Physician. 15:467–74. DOI: 10.36076/ppj.2012/15/467. PMID: 23159962.

102. Makharita MY, Amr YM, El-Bayoumy Y. 2015; Single paravertebral injection for acute thoracic herpes zoster: a randomized controlled trial. Pain Pract. 15:229–35. DOI: 10.1111/papr.12179. PMID: 24528531.

103. Stepanović A, Kolšek M, Kersnik J, Erčulj V. 2015; Prevention of post-herpetic neuralgia using transcutaneous electrical nerve stimulation. Wien Klin Wochenschr. 127:369–74. DOI: 10.1007/s00508-014-0669-3. PMID: 25471002.

104. Lee EG, Lee HJ, Hyun DJ, Min K, Kim DH, Yoon MS. 2016; Efficacy of low dose gabapentin in acute herpes zoster for preventing postherpetic neuralgia: a prospective controlled study. Dermatol Ther. 29:184–90. DOI: 10.1111/dth.12331. PMID: 26799145.

105. Cui JZ, Zhang XB, Zhu P, Zhao ZB, Geng ZS, Zhang YH, et al. 2017; Effect of repetitive intracutaneous injections with local anesthetics and steroids for acute thoracic herpes zoster and incidence of postherpetic neuralgia. Pain Med. 18:1566–72. DOI: 10.1093/pm/pnw190. PMID: 27492741.

106. Ni J, Wang X, Tang Y, Yang L, Zeng Y, Guo Y. 2017; Subcutaneous injection of triamcinolone and lidocaine to prevent postherpetic neuralgia. Pain Physician. 20:397–403. PMID: 28727702.

107. Cui JZ, Zhang JW, Yan F, Yang XN, Wang XL, Zhao ZB, et al. 2018; Effect of single intra-cutaneous injection for acute thoracic herpes zoster and incidence of postherpetic neuralgia. Pain Manag Nurs. 19:186–94. DOI: 10.1016/j.pmn.2017.09.002. PMID: 29153295.

108. Bulilete O, Leiva A, Rullán M, Roca A, Llobera J. PHN Group. 2019; Efficacy of gabapentin for the prevention of postherpetic neuralgia in patients with acute herpes zoster: a double blind, randomized controlled trial. PLoS One. 14:e0217335. DOI: 10.1371/journal.pone.0217335. PMID: 31166976. PMCID: PMC6550400.

109. Zheng S, Li X, Yang X, He L, Xue Y, Yang Z. 2019; Ultrasound-guided cervical nerve root block for the treatment of acute cervical herpes zoster: a randomized controlled clinical study. Pain Pract. 19:500–9. DOI: 10.1111/papr.12770. PMID: 30734476.

110. Pasqualucci A, Pasqualucci V, Galla F, De Angelis V, Marzocchi V, Colussi R, et al. 2000; Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone. Acta Anaesthesiol Scand. 44:910–8. DOI: 10.1034/j.1399-6576.2000.440803.x. PMID: 10981565.

111. Wood MJ, McKendrick MW, Freris MW, Jeal SC, Jones DA, Gilbert AM. 1994; Trough plasma acyclovir concentrations and safety of oral acyclovir, 800 mg five times daily for 7 days in elderly patients with herpes zoster. J Antimicrob Chemother. 33:1245–9. DOI: 10.1093/jac/33.6.1245. PMID: 7928819.

112. Clemmensen OJ, Andersen KE. 1984; ACTH versus prednisone and placebo in herpes zoster treatment. Clin Exp Dermatol. 9:557–63. DOI: 10.1111/j.1365-2230.1984.tb00859.x. PMID: 6388918.

113. Eaglstein WH, Katz R, Brown JA. 1970; The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA. 211:1681–3. DOI: 10.1001/jama.1970.03170100043009. PMID: 4905733.

114. Harding SP, Porter SM. 1991; Oral acyclovir in herpes zoster ophthalmicus. Curr Eye Res. 10 Suppl:177–82. DOI: 10.3109/02713689109020376. PMID: 1864092.

115. Keczkes K, Basheer AM. 1980; Do corticosteroids prevent post-herpetic neuralgia? Br J Dermatol. 102:551–5. DOI: 10.1111/j.1365-2133.1980.tb07654.x. PMID: 7387900.

116. Hügler P, Siebrecht P, Hoffmann K, Stücker M, Windeler J, Altmeyer P, et al. 2002; Prevention of postherpetic neuralgia with varicella-zoster hyperimmune globulin. Eur J Pain. 6:435–45. DOI: 10.1016/S1090-3801(02)00046-0. PMID: 12413432.

117. Cui JZ, Zhang JW, Zhang Y, Ma ZL. 2016; Efficacy of intracutaneous methylene blue injection for moderate to severe acute thoracic herpes zoster pain and prevention of postherpetic neuralgia in elderly patients. Nan Fang Yi Ke Da Xue Xue Bao. 36:1377–81. Chinese. PMID: 27777201.

118. Manabe H, Dan K, Hirata K, Hori K, Shono S, Tateshi S, et al. 2004; Optimum pain relief with continuous epidural infusion of local anesthetics shortens the duration of zoster-associated pain. Clin J Pain. 20:302–8. DOI: 10.1097/00002508-200409000-00004. PMID: 15322436.

119. Harding SP, Lipton JR, Wells JC, Campbell JA. 1986; Relief of acute pain in herpes zoster ophthalmicus by stellate ganglion block. Br Med J (Clin Res Ed). 292:1428. DOI: 10.1136/bmj.292.6533.1428. PMID: 3087456. PMCID: PMC1340431.

120. Wan C, Dong DS, Song T. 2019; High-voltage, long-duration pulsed radiofrequency on Gasserian ganglion improves acute/subacute zoster-related trigeminal neuralgia: a randomized, double-blinded, controlled trial. Pain Physician. 22:361–8. DOI: 10.36076/ppj/2019.22.361. PMID: 31337167.

121. Arvin AM. 1996; Varicella-zoster virus. Clin Microbiol Rev. 9:361–81. DOI: 10.1128/CMR.9.3.361. PMID: 8809466. PMCID: PMC172899.

122. Harpaz R, Nagel MA, Schmader K, Tyring SK, Yawn BP. 2012; Roundtable on postherpetic neuralgia--what, why, how long, and what's next? Popul Health Manag. 15:385–90. DOI: 10.1089/pop.2012.1562. PMID: 23088665.

123. Woolf CJ. 1994; A new strategy for the treatment of inflammatory pain. Prevention or elimination of central sensitization. Drugs. 47 Suppl 5:1–9. DOI: 10.2165/00003495-199400475-00003. PMID: 7525180.

124. Riopelle JM, Naraghi M, Grush KP. 1984; Chronic neuralgia incidence following local anesthetic therapy for herpes zoster. Arch Dermatol. 120:747–50. DOI: 10.1001/archderm.1984.01650420057016. PMID: 6721540.

125. Li Q, Chen N, Yang J, Zhou M, Zhou D, Zhang Q, et al. 2009; Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev. (2):CD006866. DOI: 10.1002/14651858.CD006866.pub3. PMID: 24500927.

126. Epstein E. 1981; Treatment of herpes zoster and postzoster neuralgia by subcutaneous injection of triamcinolone. Int J Dermatol. 20:65–8. DOI: 10.1111/j.1365-4362.1981.tb05299.x. PMID: 7203770.

127. Johansson A, Bennett GJ. 1997; Effect of local methylprednisolone on pain in a nerve injury model. A pilot study. Reg Anesth. 22:59–65. DOI: 10.1016/S1098-7339(06)80057-X. PMID: 9010948.

128. Davies RG, Myles PS, Graham JM. 2006; A comparison of the analgesic efficacy and side-effects of paravertebral vs epidural blockade for thoracotomy--a systematic review and meta-analysis of randomized trials. Br J Anaesth. 96:418–26. DOI: 10.1093/bja/ael020. PMID: 16476698.

129. Joshi GP, Bonnet F, Shah R, Wilkinson RC, Camu F, Fischer B, et al. 2008; A systematic review of randomized trials evaluating regional techniques for postthoracotomy analgesia. Anesth Analg. 107:1026–40. DOI: 10.1213/01.ane.0000333274.63501.ff. PMID: 18713924.

130. Makharita MY, Amr YM. 2020; Effect of repeated paravertebral injections with local anesthetics and steroids on prevention of post-herpetic neuralgia. Pain Physician. 23:565–72. DOI: 10.36076/ppj.2020.23.565. PMID: 33185373.

131. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, et al. 2007; Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet. 370:937–48. DOI: 10.1016/S0140-6736(07)61444-5. PMID: 17869634.

132. Li T, Puhan MA, Vedula SS, Singh S, Dickersin K. 2011; Network meta-analysis-highly attractive but more methodological research is needed. BMC Med. 9:79. DOI: 10.1186/1741-7015-9-79. PMID: 21707969. PMCID: PMC3159133.